Viewing Study NCT05588908


Ignite Creation Date: 2025-12-26 @ 10:58 AM
Ignite Modification Date: 2025-12-29 @ 3:16 PM
Study NCT ID: NCT05588908
Status: UNKNOWN
Last Update Posted: 2022-10-20
First Post: 2022-10-17
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase Ib/II Study of Recombinant Anti-IL-1β Humanized Monoclonal Antibody Injection in Chinese Participants With Acute Gout
Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module